Targeting the ISG15+STAT1+ monocyte-driven inflammatory storm with Fedratinib in traumatic lung injury via the JAK2/STAT3/PIM1 axis - Top-Institutions - MDSpire

Targeting the ISG15+STAT1+ monocyte-driven inflammatory storm with Fedratinib in traumatic lung injury via the JAK2/STAT3/PIM1 axis

  • By

  • Kun Zhang

  • Dan Li

  • Le Gao

  • Mingwei Chen

  • June 19, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    NYU Langone Hospitals
    NYU Langone Hospitals

    New York, New York

    Key Differentiators

    • Pulmonology

  • #2

    UCSF Health – UCSF Medical Center
    UCSF Health – UCSF Medical Center

    San Francisco, California

    Key Differentiators

    • Pulmonology

Original Source(s)

Targeting the ISG15+STAT1+ monocyte-driven inflammatory storm with Fedratinib in traumatic lung injury via the JAK2/STAT3/PIM1 axis

  • by Kun Zhang, Dan Li, Le Gao, Mingwei Chen

  • June 19, 2026

Related Content

Case Report: Heparin resistance as the harbinger of heparin-induced thrombocytopenia in acute pulmonary embolism

Respiratory safety and resource utilization in ERCP: a comparative study of high-flow nasal oxygen, conventional mask, and general anesthesia in high-risk populations

Electrical Impedance Tomography in Nonintubated Patients: Advancing Validation and Defining Clinical Value